Annals of the Rheumatic Diseases collection on osteoarthritis (2018-2023): hopes and disappointments
- PMID: 37734879
- DOI: 10.1136/ard-2023-224840
Annals of the Rheumatic Diseases collection on osteoarthritis (2018-2023): hopes and disappointments
Keywords: osteoarthritis; outcome assessment, health care; therapeutics.
Conflict of interest statement
Competing interests: The author is the founder and CEO of 4Moving Biotech, a company involved in the development of GLP1RAs for OA treatment.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
